butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Coadministration of CYP3A4 inducers may perhaps lower sufentanil stages and efficacy, perhaps precipitating withdrawal syndrome in clients which have designed Bodily dependence to sufentanil. Discontinuat